US/UK/Canada

Share

Contacts

  • Fredrik Pallin

    VP Public Relations


    +46 708 114 115

    • Links

    Pick a time period -
    Tags ( Active)

    Digital Obesity Care Reaches All Income Groups – But Financial Barriers Create Health Inequalities

    New real-world data from over 40,000 patients show that digital obesity care produces significant and sustained weight loss even with low medication doses. The studies, presented at the European Congress on Obesity (ECO) 2026 in Istanbul, also reveal that finances are the single most common reason for treatment discontinuation, and that only 8 percent of low-income patients who are forced to stop their care later manage to resume it.At this year’s ECO congress, Swedish Yazen Health is presenting two comprehensive studies (PO4.202 and PO4.209) based on data from over 40,000 patients across

    Beyond the Scale: New Data Shows Patients On Weight Loss Injections Make Financial Saving

    LONDON – [April 16th, 2026] – While the health benefits of modern obesity treatment are well-documented, new internal patient data from Yazen  reveals a significant secondary impact: substantial monthly cost savings for patients. As the global conversation around obesity often focuses on the price of medication, these findings suggest that effective, holistic treatment actually strengthens household budgets by transforming long-term consumption habits.The data, drawn from a pan-European survey of

    Yazen Secures €6.5 Million Credit Facility from HSBC Innovation Banking

    Secured financing from HSBC Innovation Banking supports accelerated expansion and optimises funding mix Yazen, the leading digital obesity clinic offering medically supervised weight loss through a combination of lifestyle interventions and modern medications, has secured a €6.5 million credit facility from HSBC Innovation Banking. The financing marks a significant milestone for the company as it accelerates its growth and reinforces its financial flexibility.2025 marked another record-breaking year for the digital healthcare provider Yazen. Revenue increased from approximately €15.7

    Yazen doubles revenue and continues expansion in Europe

    2025 marked another record-breaking year for the digital healthcare provider Yazen. Revenue increased from approximately €15.7 million to nearly €29.4 million – a growth of 87 percent. At the same time, gross profit doubled to around €16.5 million. Yazen ended the year with over 37,000 active patients, and more than 53,000 patients have been treated since its inception. Collectively, patients have lost 643 tonnes in weight – a clear indication that Yazen’s combination of modern medications and lifestyle changes delivers effective, sustainable results. Throughout the year, the

    Yazen Presents New Real-World data on Digital Obesity Care at Nordic Obesity Meeting 2026

    Today, at the Nordic Obesity Meeting (NOM) 2026  in Stockholm, Yazen presented new scientific insights into patient engagement and continuity of care within a fully digital obesity treatment model. Over two days in Stockholm, Nordic Obesity Meeting brings together more than 200 participants on site, alongside 100 digital participants, representing leading obesity expertise from across all Nordic countries. During the first day of the meeting, Yazen delivered an oral scientific presentation entitled “High-Volume Patient–Caregiver Interactions in a Fully

    YAZEN UNVEILS FESTIVE FOOD SURVIVAL GUIDE FOR MILLIONS ON WEIGHT LOSS DRUGS

    LONDON – [December 11, 2025] – As the countdown to Christmas begins, for the 1.5 million estimated people in the UK using GLP-1/GIP medications, the festive food noise is deafening and for many, the fear of navigating the festive period without 'falling off the wagon' is the number one concern. Yazen , a digital healthcare provider specialising in obesity treatment across Europe, is tackling the 'festive food noise fear' with practical advice and a new online series with world-class chef Tristan Welch and TV icon, Gemma Collins.   Erik Dunåker,

    Yazen named the fastest-growing startup in the Nordics and Benelux in the Sifted 100 Leaderboard

    Yazen has been named the fastest-growing startup in the Nordics and Benelux, according to The Sifted 100: Nordics and Benelux Europe Leaderboard. The ranking highlights the 100 startups that have achieved the highest percentage revenue growth over the past three financial years.“This is a proud moment! Being ranked number one among so many fantastic companies in the region demonstrates the strength of our model and our team. A huge thank you to our employees, partners, and all patients who are part of our journey,” says Fredrik Meurling, CEO of Yazen. In just one year, Yazen has grown

    Yazen presents strong research results with lasting weight loss and high adherence to medical treatment for weight loss

    At the European Congress on Obesity  (ECO) in Malaga, Yazen presents data on over 30,000 treated patients (in Sweden, Norway, Denmark, the Netherlands, Germany and Spain), showing significant sustainable health improvements with its digital care model. With an average weight loss of 16.4% after 12 months, maintenance of weight loss after 18 months, as well as higher adherence to treatment than seen in studies, the results confirm that digital care can be an effective and long-term alternative to traditional obesity care. The Yazen model, which combines modern

    Yazen and Withings Health Solutions announce new partnership – moving beyond BMI for more accurate health measurements

    LUND and ISSY-LES-MOULINEAUX, March 4, 2025 – Yazen, a leader in obesity treatment, is partnering with Withings Health Solutions, a leader in digital health technology. Together, they are taking a step away from the limitations of BMI and offering a more nuanced approach to health assessment through modern technology. With Withings' advanced scales, Yazen patients will have access to detailed body composition analyses that measure far more than just weight – a crucial advancement in the treatment of obesity and metabolic diseases. Body Mass Index (BMI) has long been used as a

    Yazen expands in Scandinavia through acquisition of Danish Medstart

    Yazen, the leading digital healthcare provider for obesity treatment, has acquired the Danish company Medstart. Medstart, established in Denmark and Norway, shares Yazen’s holistic approach to obesity care, making this acquisition a natural step in Yazen’s ambitious growth journey.Oliver Willacy, CEO Medstart and Fredrik Meurling, CEO Yazen Medstart has successfully developed a model combining modern medications with lifestyle changes and support from multidisciplinary teams, aligning closely with Yazen’s methodology. The acquisition marks Yazen’s entry into the Danish market and

    Yazen closes oversubscribed €19.5 million series A round to accelerate growth and international expansion

    Yazen Health, the leading healthcare platform dedicated to combating obesity with modern weight loss medication and lifestyle changes, announced today the successful closing of an oversubscribed €19.5 million Series A funding round. With this funding, the company strengthens its position as a pioneer in obesity treatment and sets its sights on international expansion. Mikael Hed, new chariman and Fredrik Meurling, CEO Yazen The funding round was co-led by Evli Growth Partners (Finland) and Helsana HealthInvest (Switzerland) with participation from Almaz Capital (Germany) and Yabeo

    Yazen Health Hosts Live Panel "The Balancing Act - The Truth About Obesity"

    Esteemed Experts Discuss Cutting-Edge Obesity Treatment LONDON -- June 20, 2024 – Yazen Health, a pioneering digital healthcare provider specialising in obesity treatment, will host a live panel discussion titled "The Balancing Act - The Truth About Obesity" on Thursday, June 20th from 12:30 - 13:30 BST. The virtual event will be streamed live on LinkedIn. The esteemed panel brings together leading experts in obesity research, endocrinology, psychology, and digital health solutions to explore the latest advancements and holistic approaches to obesity care. Attendees will gain

    YAZEN HEALTH RESEARCH REVEALS OVER A THIRD OF BRITS WRONGLY BELIEVE OBESITY IS A PERSONAL CHOICE

    New survey uncovers widespread misunderstandings around obesity as a disease LONDON, 12th June 2024 – Despite obesity's tremendous toll on public health and the economy, myths and misconceptions persist with over one-third (37%) of Brits mistakenly viewing it as a personal choice rather than a chronic medical disease and 43% attributing obesity to laziness. This is according to striking new independent research from Yazen Health , a leading digital provider of comprehensive, medically-assisted weight loss treatment. The results highlight a concerning

    This is how 10,000 patients lost 100 tons of weight

    Patients of the digital healthcare provider Yazen have now collectively lost 100 tons with a new method that combines lifestyle changes with modern drugs. On average, a patient loses 12 percent of their body weight in 6 months, which corresponds to an average of 12 kg. Since its launch in Sweden just over a year ago, the digital healthcare provider Yazen has  around 10,000 patients. These patients have lost more than 100 tons combined and reduced their waist size by just over 1,000 meters. In addition, reduced calorie intake has meant reduced costs by GRP 3m for the patients.–

    Why don't we give obese patients the care they need?

    Today, March 4th, is World Obesity Day, which aims to raise awareness of obesity and the many other diseases that are caused as a result of excess weight and obesity. The obesity epidemic is one of the biggest health problems we face. It is estimated that by 2025 1.9 billion people globally will suffer from morbid obesity, one in four adults. Among children, obesity will increase by 100 percent between the years 2020 and 2035.The cost to society is estimated at 4 billion dollars.   In Sweden, more than half of all adults are overweight, 18 percent of which are classified as

    Yazen raises €3.1M for expansion

    Yazen is a digital weight-loss clinic using a combination of lifestyle changes and medication. The company has now raised €3.1M to continue its expansion in Europe. Founders of Yazen: Fredrik Meurling, CEO, Otto Bretz, CTO, Magnus Nyhlén, MD and entrepreneur, and Martin Carlsson, Associate Professor, MD and specialist in endocrinology.  Yazen started 2021 with the mission to defeat obesity. With the help of a team of doctors, dietitians, psychologists and personal trainers, patients are treated using a combination of modern medication and lifestyle changes via a digital platform.

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media